Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
CB3717
Description:
An antifolate drug that inhibits thymidylate synthase and was investigated as an anticancer agent in clinical and laboratory settings.
Primary topic:
Biochemical and Molecular Research (26%)
Related topics:
Biochemical and Molecular Research (26%),
Folate and B Vitamins Research (10%),
Drug Transport and Resistance Mechanisms (9%)
OpenAlex ID:
keywords/cb3717
bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways.
1993
·
T C Fisher
, A E Milner
, et al.
·
PubMed
·
261
Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
1995
·
G R Westerhof
, J H Schornagel
, et al.
·
Molecular Pharmacology
·
225
Mechanism of cell-death following thymidylate synthase inhibition - 2'-deoxyuridine-5'-triphosphate accumulation, DNA damage, and growth-inhibition following exposure to CB3717 and dipyridamole.
1991
·
Nicola Curtin
, AL HARRIS
, et al.
·
PubMed
·
181
Folate-based thymidylate synthase inhibitors as anticancer drugs
1995
·
A.L. Jackman
, A.H. Calvert
·
Annals of Oncology
·
171
The H circles of Leishmania tarentolae are a unique amplifiable system of oligomeric DNAs associated with drug resistance.
1988
·
T C White
, F Fase-Fowler
, et al.
·
Journal of Biological Chemistry
·
131
Thymidylate synthase inhibitors.
1996
·
N Touroutoglou
, R Pazdur
·
PubMed
·
125
Biochemical effects of a quinazoline inhibitor of thymidylate synthetase, N-(4-(N-((2-amino-4-hydroxy-6-quinazolinyl)methyl)prop-2-ynylamino)benzoyl)-l-glutamic acid (CB3717), on human lymphoblastoid cells
1983
·
Robert C. Jackson
, Ann L. Jackman
, et al.
·
Biochemical Pharmacology
·
114
Mechanisms of acquired resistance to the quinazoline thymidylate synthase inhibitor ZD1694 (Tomudex) in one mouse and three human cell lines
1995
·
AL Jackman
, LR Kelland
, et al.
·
British Journal of Cancer
·
105
PDF
A phase I evaluation of the quinazoline antifolate thymidylate synthase inhibitor, N10-propargyl-5,8-dideazafolic acid, CB3717.
1986
·
A H Calvert
, D L Alison
, et al.
·
Journal of Clinical Oncology
·
103
Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate.
1983
·
H Diddens
, D Niethammer
, et al.
·
PubMed
·
102
Modulation of anti-metabolite effects
1984
·
Ann L. Jackman
, Gordon A. Taylor
, et al.
·
Biochemical Pharmacology
·
98
Variations in patterns of DNA damage induced in human colorectal tumor cells by 5-fluorodeoxyuridine: implications for mechanisms of resistance and cytotoxicity.
1992
·
C E Canman
, H Y Tang
, et al.
·
Proceedings of the National Academy of Sciences
·
87
Structures of Leishmania major Pteridine Reductase Complexes Reveal the Active Site Features Important for Ligand Binding and to Guide Inhibitor Design
2005
·
Alexander W. Schüttelkopf
, Larry W. Hardy
, et al.
·
Journal of Molecular Biology
·
82
Membrane transport of natural folates and antifolate compounds in murine L1210 leukemia cells: role of carrier- and receptor-mediated transport systems.
1991
·
G R Westerhof
, G Jansen
, et al.
·
PubMed
·
80
Folate-based thymidylate synthase inhibitors in cancer chemotherapy
1997
·
Yuzuru Takemura
, Ann L. Jackman
·
Anti-Cancer Drugs
·
77
Increased expression and characterization of two distinct folate binding proteins in murine erythroleukemia cells
1994
·
Kevin E. Brigle
, Michael J. Spinella
, et al.
·
Biochemical Pharmacology
·
77
Binding of the anticancer drug ZD1694 to E. coli thymidylate synthase: assessing specificity and affinity
1996
·
Earl E Rutenber
, Robert M Stroud
·
Structure
·
72
PDF
Unusual Binding Stoichiometries and Cooperativity Are Observed during Binary and Ternary Complex Formation in the Single Active Pore of R67 Dihydrofolate Reductase, a D 2 Symmetric Protein
1996
·
Thomas D. Bradrick
, Joseph M. Beechem
, et al.
·
Biochemistry
·
63
TomudexTM (ZD1694): from concept to care, a programme in rational drug discovery
1996
·
Ann L. Jackman
, Kenneth R. Harrap
, et al.
·
Investigational New Drugs
·
62
Multiple membrane transport systems for the uptake of folate-based thymidylate synthase inhibitors.
1990
·
G Jansen
, J H Schornagel
, et al.
·
PubMed
·
57
Thymidylate synthase: A target for anticancer drug design
1989
·
K.R. Harrap
, A.L. Jackman
, et al.
·
Advances in Enzyme Regulation
·
54
Phase II study of a novel antifolate, N10-propargyl-5,8 dideazafolic acid (CB3717), in malignant mesothelioma.
1986
·
B M Cantwell
, M Earnshaw
, et al.
·
PubMed
·
48
Thymidylate synthase inhibitors: The in vitro activity of a series of heterocyclic benzoyl ring modified 2-desamino-2-methyl-N10-substituted-5,8-dideazafolates
1991
·
A.L. Jackman
, P.R. Marsham
, et al.
·
Advances in Enzyme Regulation
·
47
Selection and properties of Leishmania tropica resistant to 10-propargyl-5,8-dideazafolate, an inhibitor of thymidylate synthetase
1985
·
E GARVEY
, J CODERRE
, et al.
·
Molecular and Biochemical Parasitology
·
41
The renal effects of N10-propargyl-5,8-dideazafolic acid (CB3717) and a non-nephrotoxic analogue ICI D1694, in mice
1991
·
DI Jodrell
, DR Newell
, et al.
·
British Journal of Cancer
·
39
PDF
Show more works
View as search
Works count:
119
Citation count:
3,023
Year
Topic
Type